Mechanistically, CEP55 overexpression leads to cancer cell transformation, proliferation, mesenchymal transition, and invasion by directly interacting with the p110 catalytic subunit of PI3K and upregulating the PI3K/AKT pathway [47]. This evidence concerns the gene AKT1 and cancer.